SCYNEXIS Inc (SCYX) stock
SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3071% below fair value
$2.85−0.06 (-2.06%)
Close on Nov 17, 2026Market cap $28.36MP/E –Yield –
Scynexis profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Scynexis's profit margin for the twelve months ending Jun 30, 2026 was -53.3%. For fiscal 2025 it was -41.8%, against -568.3% the year before. The highest annual figure on record is 47.8% in fiscal 2023.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -41.8% | +526.5 |
| FY2024 | Dec 31, 2024 | -568.3% | −616.1 |
| FY2023 | Dec 31, 2023 | 47.8% | +1281.6 |
| FY2022 | Dec 31, 2022 | -1233.7% | −984.0 |
| FY2021 | Dec 31, 2021 | -249.7% | +44138.7 |
| FY2019 | Dec 31, 2019 | -44388.4% | −39537.1 |
| FY2018 | Dec 31, 2018 | -4851.4% | +4899.6 |
| FY2017 | Dec 31, 2017 | -9751.0% | +1917.9 |
| FY2016 | Dec 31, 2016 | -11668.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 3147.7% | +5245.3 |
| Q4 FY2025 | Dec 31, 2025 | 65.7% | +519.5 |
| Q3 FY2025 | Sep 30, 2025 | -2572.2% | −2146.7 |
| Q2 FY2025 | Jun 30, 2025 | -504.8% | +1459.6 |
| Q1 FY2025 | Mar 31, 2025 | -2097.7% | −2127.6 |
| Q4 FY2024 | Dec 31, 2024 | -453.7% | −115.9 |
| Q3 FY2024 | Sep 30, 2024 | -425.5% | −325.7 |
| Q2 FY2024 | Jun 30, 2024 | -1964.4% | −2057.4 |
| Q1 FY2024 | Mar 31, 2024 | 29.9% | +3027.8 |
| Q4 FY2023 | Dec 31, 2023 | -337.9% | +608.9 |
| Q3 FY2023 | Sep 30, 2023 | -99.8% | +1800.3 |
| Q2 FY2023 | Jun 30, 2023 | 93.0% | +1101.7 |
| Q1 FY2023 | Mar 31, 2023 | -2997.9% | −2204.4 |
| Q4 FY2022 | Dec 31, 2022 | -946.8% | +3951.5 |
| Q3 FY2022 | Sep 30, 2022 | -1900.1% | −1782.8 |
| Q2 FY2022 | Jun 30, 2022 | -1008.7% | −969.9 |
| Q1 FY2022 | Mar 31, 2022 | -793.4% | +13948.7 |
| Q4 FY2021 | Dec 31, 2021 | -4898.3% | +30895.4 |
| Q3 FY2021 | Sep 30, 2021 | -117.2% | −3151.6 |
| Q1 FY2021 | Mar 31, 2021 | -38.8% | −587.2 |
| Q2 FY2019 | Jun 30, 2019 | -14742.1% | +2065.7 |
| Q1 FY2019 | Mar 31, 2019 | -35793.8% | −29540.6 |
| Q4 FY2018 | Dec 31, 2018 | 3034.4% | +14893.8 |
| Q3 FY2018 | Sep 30, 2018 | 548.4% | +13675.0 |
| Q2 FY2018 | Jun 30, 2018 | -16807.8% | −10246.9 |
| Q1 FY2018 | Mar 31, 2018 | -6253.1% | +1354.7 |
| Q4 FY2017 | Dec 31, 2017 | -11859.4% | −6553.2 |
| Q3 FY2017 | Sep 30, 2017 | -13126.6% | +4417.2 |
| Q2 FY2017 | Jun 30, 2017 | -6560.9% | – |
| Q1 FY2017 | Mar 31, 2017 | -7607.8% | – |
| Q4 FY2016 | Dec 31, 2016 | -5306.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -17543.8% | – |
See a number that looks wrong?